Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EluSys: Seek and destroy

The human immune system is a fairly efficient defense system against foreign antigens, including pathogenic bacteria, viruses and toxins. However, despite its layers of surveillance, the immune system is not perfect. EluSys Therapeutics Inc. hopes to exploit one aspect of the humoral immune system, while bypassing a portion of the antigen-recognition cascade, to both enhance protection against blood-borne pathogens and prevent the self-recognition of autoimmune reactions.

EluSys' technology is based upon its heteropolymer (HP) system for binding particular antigens and

Read the full 798 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers